Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiad424 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Stephanie Jost und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Innate and Comparative Immunology, Center for Human Systems Immunology, Department of Surgery, Duke University School of Medicine, Durham…. Hauptthemen laut MEDLINE: Killer Cells, Natural, JC Virus, Up-Regulation, GPI-Linked Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
JC polyomavirus (JCPyV) causes progressive multifocal leukoencephalopathy (PML), a potentially fatal complication of severe immune suppression with no effective treatment. Natural killer (NK) cells play critical roles in defense against viral infections; however, NK-cell response to JCPyV infection remains unexplored.
Methods
NK- and T-cell responses against the JCPyV VP1 were compared using intracellular cytokine staining upon stimulation with peptide pools. A novel flow cytometry-based assay was developed to determine NK-cell killing efficiency of JCPyV-infected astrocyte-derived SVG-A cells. Blocking antibodies were used to evaluate the contribution of NK-cell receptors in immune recognition of JCPyV-infected cells.
Results
In about 40% of healthy donors, we detected robust CD107a upregulation and IFN-γ production by NK cells, extending beyond T-cell responses. Next, using the NK-cell–mediated killing assay, we showed that coculture of NK cells and JCPyV-infected SVG-A cells leads to a 60% reduction in infection, on average. JCPyV-infected cells had enhanced expression of ULBP2—a ligand for the activating NK-cell receptor NKG2D, and addition of NKG2D blocking antibodies decreased NK-cell degranulation.
Conclusions
NKG2D-mediated activation of NK cells plays a key role in controlling JCPyV replication and may be a promising immunotherapeutic target to boost NK-cell anti-JCPyV activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Innate and Comparative Immunology, Center for Human Systems Immunology, Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
- Center for Virology and Vaccine Research, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Infectious Diseases, Department of Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
- Biogen, Inc, Cambridge, Massachusetts, USA.
- Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: C Sabrina Tan
Förderung
- NINDS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Jost, S., Ahn, J., Chen, S., Yoder, T., Gikundiro, K. E., Lee, E., Gressens, S. B., Kroll, K., Craemer, M., Kaynor, G. C., Lifton, M., & Tan, C. S. (2024). Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad424
Vancouver
Jost S, Ahn J, Chen S, Yoder T, Gikundiro KE, Lee E, et al. Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad424
BibTeX
@article{Jost2024,
author = {Jost, Stephanie and Ahn, Jenny and Chen, Sarah and Yoder, Taylor and Gikundiro, Kayitare Eunice and Lee, Esther and Gressens, Simon B and Kroll, Kyle and Craemer, Melissa and Kaynor, G Campbell and Lifton, Michelle and Tan, C Sabrina},
title = {Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiad424}
}
EUVIMED